| Tag |
First Indicator |
Second Indicator |
Subfields |
| LEADER |
00000nam a22000001i 4500 |
| 001 |
in00005606321 |
| 006 |
m |o d | |
| 007 |
cr |n||||||||| |
| 008 |
241204s2025 nju o 001 0 eng d |
| 005 |
20250511175540.3 |
| 020 |
|
|
|a 9781394249190 (electronic bk.)
|
| 020 |
|
|
|a 1394249195 (electronic bk.)
|
| 020 |
|
|
|z 9781394249169
|
| 020 |
|
|
|z 1394249160
|
| 035 |
|
|
|a wil6009863
|
| 035 |
|
|
|a (NhCcYBP)wil6009863
|
| 040 |
|
|
|a NhCcYBP
|b eng
|e rda
|c NhCcYBP
|
| 050 |
|
4 |
|a RM301.25
|
| 060 |
|
4 |
|a QV 745
|
| 082 |
0 |
4 |
|a 615.1/9
|2 23/eng/20241009
|
| 245 |
0 |
0 |
|a Computational methods for rational drug design /
|c edited by Mithun Rudrapal.
|
| 264 |
|
1 |
|a Hoboken, New Jersey. :
|b Wiley,
|c [2025]
|
| 300 |
|
|
|a 1 online resource (pages cm.)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Includes index.
|
| 505 |
0 |
|
|a Molecular modeling and drug design -- Bioactive small molecules and drug discovery -- Novel drug targets for small molecule-based drug discovery -- Computer-assisted methods and tools for structure- and ligand-based drug design -- Virtual screening and lead discovery -- ADMET and physicochemical assessments in drug design -- In silico modelling and drug design -- Pharmacophore modelling in drug design -- Scaffold hopping and de novo drug design -- Fragment-based drug design and drug discovery -- AI/ML approaches in drug design -- Network-based methods in drug discovery -- Rational design of natural products for drug discovery -- Rational design of enzyme inhibitors and drug discovery -- Rational design of peptides and protein molecules in drug discovery -- Rational design of drugs for neurodegenerative disorders -- Rational design of anti-inflammatory therapeutics -- Rational design of antibacterials for multi-drug resistant infections -- Rational design of antiviral therapeutics -- Rational design of anticancer therapeutics -- Protac and Protide strategies in drug design -- Advancing Lung Cancer Treatment Through ALK Receptor-Targeted Drug Metabolism and Pharmacokinetics -- Targeting Intrinsically Disordered Proteins (IDPs) in Drug Discovery : Opportunities and Challenges.
|
| 520 |
|
|
|a "Drug design is the process of finding new medications based on the knowledge of a biological target. In the most basic sense, drug design involves the design of molecules that are complementary in shape and charge to the molecular target with which they interact and bind. Frequently, it relies on computer modeling techniques and bioinformatics approaches. In addition to small molecules, biopharmaceuticals and especially peptide-based therapeutics are an increasingly important class of drugs and computational methods for improving the affinity, selectivity, and stability of these protein-based therapeutics have also gained great advances"--
|c Provided by publisher.
|
| 588 |
|
|
|a Description based on print version record.
|
| 650 |
|
0 |
|a Drugs
|x Design.
|
| 650 |
1 |
2 |
|a Drug Design
|
| 650 |
2 |
2 |
|a Models, Molecular
|
| 700 |
1 |
|
|a Rudrapal, Mithun,
|e editor.
|
| 776 |
0 |
8 |
|i Online version:
|t Computational methods for rational drug design
|d Hoboken, New Jersey. : Wiley, [2025]
|z 9781394249183
|w (DLC) 2024045118
|
| 776 |
0 |
8 |
|c Original
|z 9781394249169
|z 1394249160
|w (DLC) 2024045117
|
| 856 |
4 |
0 |
|u http://proxy.library.tamu.edu/login?url=https://onlinelibrary.wiley.com/book/10.1002/9781394249190
|z Connect to the full text of this electronic book
|t 0
|
| 955 |
|
|
|a Wiley EBA purchase
|
| 975 |
|
|
|p Wiley UBCM Full Collection 2024
|
| 976 |
|
|
|a 6009863
|
| 999 |
f |
f |
|s 2f56aefd-bd19-4b50-a7a0-f7ce8c1315e4
|i 019c116c-f12b-4436-8cdc-bc8ef7b40388
|t 0
|
| 952 |
f |
f |
|a Texas A&M University
|b College Station
|c Electronic Resources
|d Available Online
|t 0
|e RM301.25
|h Library of Congress classification
|
| 998 |
f |
f |
|a RM301.25
|t 0
|l Available Online
|